Theranostics - a sure cure for cancer after 100 years?

Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theranostics 2024-01, Vol.14 (6), p.2464-2488
Hauptverfasser: Song, Yangmeihui, Zou, Jianhua, Castellanos, E Alejandro, Matsuura, Naomi, Ronald, John A, Shuhendler, Adam, Weber, Wolfgang A, Gilad, Assaf A, Müller, Cristina, Witney, Timothy H, Chen, Xiaoyuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2488
container_issue 6
container_start_page 2464
container_title Theranostics
container_volume 14
creator Song, Yangmeihui
Zou, Jianhua
Castellanos, E Alejandro
Matsuura, Naomi
Ronald, John A
Shuhendler, Adam
Weber, Wolfgang A
Gilad, Assaf A
Müller, Cristina
Witney, Timothy H
Chen, Xiaoyuan
description Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.
doi_str_mv 10.7150/thno.96675
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11024861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3043778598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-d3a19aa6abdff813a7b400153ca5a927dae860c5d3e5d0743b456e384e846ac83</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbKm9-AMkRxFSd7ufORUpfkHBSz0vk83ERtJs3U2F_nsTW0udw8zAvLzv8BByzehEM0nv21XjJ5lSWp6RITPcpFoJen6yD8g4xk_alaDTjGWXZMCNEkoJMyRqucIAjY9t5WKSJpDEbcDE9a30IXHQOAwJlG3XGaXJDiHE2RW5KKGOOD7MEXl_elzOX9LF2_Pr_GGROs5NmxYcWAagIC_K0jAOOheUMskdSMimugA0ijpZcJQF1YLnQirkRqARCpzhIzLb-262-RoLh00boLabUK0h7KyHyv6_NNXKfvhvyxidCqNY53B7cAj-a4uxtesqOqxraNBvo-VUcK2NzPqwu73UBR9jwPKYw6jtYdsetv2F3YlvTj87Sv_Q8h9ts3nY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043778598</pqid></control><display><type>article</type><title>Theranostics - a sure cure for cancer after 100 years?</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Song, Yangmeihui ; Zou, Jianhua ; Castellanos, E Alejandro ; Matsuura, Naomi ; Ronald, John A ; Shuhendler, Adam ; Weber, Wolfgang A ; Gilad, Assaf A ; Müller, Cristina ; Witney, Timothy H ; Chen, Xiaoyuan</creator><creatorcontrib>Song, Yangmeihui ; Zou, Jianhua ; Castellanos, E Alejandro ; Matsuura, Naomi ; Ronald, John A ; Shuhendler, Adam ; Weber, Wolfgang A ; Gilad, Assaf A ; Müller, Cristina ; Witney, Timothy H ; Chen, Xiaoyuan</creatorcontrib><description>Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.</description><identifier>ISSN: 1838-7640</identifier><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.96675</identifier><identifier>PMID: 38646648</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Review</subject><ispartof>Theranostics, 2024-01, Vol.14 (6), p.2464-2488</ispartof><rights>The author(s).</rights><rights>The author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024861/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024861/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38646648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Yangmeihui</creatorcontrib><creatorcontrib>Zou, Jianhua</creatorcontrib><creatorcontrib>Castellanos, E Alejandro</creatorcontrib><creatorcontrib>Matsuura, Naomi</creatorcontrib><creatorcontrib>Ronald, John A</creatorcontrib><creatorcontrib>Shuhendler, Adam</creatorcontrib><creatorcontrib>Weber, Wolfgang A</creatorcontrib><creatorcontrib>Gilad, Assaf A</creatorcontrib><creatorcontrib>Müller, Cristina</creatorcontrib><creatorcontrib>Witney, Timothy H</creatorcontrib><creatorcontrib>Chen, Xiaoyuan</creatorcontrib><title>Theranostics - a sure cure for cancer after 100 years?</title><title>Theranostics</title><addtitle>Theranostics</addtitle><description>Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.</description><subject>Review</subject><issn>1838-7640</issn><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdRbKm9-AMkRxFSd7ufORUpfkHBSz0vk83ERtJs3U2F_nsTW0udw8zAvLzv8BByzehEM0nv21XjJ5lSWp6RITPcpFoJen6yD8g4xk_alaDTjGWXZMCNEkoJMyRqucIAjY9t5WKSJpDEbcDE9a30IXHQOAwJlG3XGaXJDiHE2RW5KKGOOD7MEXl_elzOX9LF2_Pr_GGROs5NmxYcWAagIC_K0jAOOheUMskdSMimugA0ijpZcJQF1YLnQirkRqARCpzhIzLb-262-RoLh00boLabUK0h7KyHyv6_NNXKfvhvyxidCqNY53B7cAj-a4uxtesqOqxraNBvo-VUcK2NzPqwu73UBR9jwPKYw6jtYdsetv2F3YlvTj87Sv_Q8h9ts3nY</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Song, Yangmeihui</creator><creator>Zou, Jianhua</creator><creator>Castellanos, E Alejandro</creator><creator>Matsuura, Naomi</creator><creator>Ronald, John A</creator><creator>Shuhendler, Adam</creator><creator>Weber, Wolfgang A</creator><creator>Gilad, Assaf A</creator><creator>Müller, Cristina</creator><creator>Witney, Timothy H</creator><creator>Chen, Xiaoyuan</creator><general>Ivyspring International Publisher</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240101</creationdate><title>Theranostics - a sure cure for cancer after 100 years?</title><author>Song, Yangmeihui ; Zou, Jianhua ; Castellanos, E Alejandro ; Matsuura, Naomi ; Ronald, John A ; Shuhendler, Adam ; Weber, Wolfgang A ; Gilad, Assaf A ; Müller, Cristina ; Witney, Timothy H ; Chen, Xiaoyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-d3a19aa6abdff813a7b400153ca5a927dae860c5d3e5d0743b456e384e846ac83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Yangmeihui</creatorcontrib><creatorcontrib>Zou, Jianhua</creatorcontrib><creatorcontrib>Castellanos, E Alejandro</creatorcontrib><creatorcontrib>Matsuura, Naomi</creatorcontrib><creatorcontrib>Ronald, John A</creatorcontrib><creatorcontrib>Shuhendler, Adam</creatorcontrib><creatorcontrib>Weber, Wolfgang A</creatorcontrib><creatorcontrib>Gilad, Assaf A</creatorcontrib><creatorcontrib>Müller, Cristina</creatorcontrib><creatorcontrib>Witney, Timothy H</creatorcontrib><creatorcontrib>Chen, Xiaoyuan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Yangmeihui</au><au>Zou, Jianhua</au><au>Castellanos, E Alejandro</au><au>Matsuura, Naomi</au><au>Ronald, John A</au><au>Shuhendler, Adam</au><au>Weber, Wolfgang A</au><au>Gilad, Assaf A</au><au>Müller, Cristina</au><au>Witney, Timothy H</au><au>Chen, Xiaoyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Theranostics - a sure cure for cancer after 100 years?</atitle><jtitle>Theranostics</jtitle><addtitle>Theranostics</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>14</volume><issue>6</issue><spage>2464</spage><epage>2488</epage><pages>2464-2488</pages><issn>1838-7640</issn><eissn>1838-7640</eissn><abstract>Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>38646648</pmid><doi>10.7150/thno.96675</doi><tpages>25</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1838-7640
ispartof Theranostics, 2024-01, Vol.14 (6), p.2464-2488
issn 1838-7640
1838-7640
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11024861
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Review
title Theranostics - a sure cure for cancer after 100 years?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Theranostics%20-%20a%20sure%20cure%20for%20cancer%20after%20100%20years?&rft.jtitle=Theranostics&rft.au=Song,%20Yangmeihui&rft.date=2024-01-01&rft.volume=14&rft.issue=6&rft.spage=2464&rft.epage=2488&rft.pages=2464-2488&rft.issn=1838-7640&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.96675&rft_dat=%3Cproquest_pubme%3E3043778598%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3043778598&rft_id=info:pmid/38646648&rfr_iscdi=true